Le Cesne A - Search Results

1

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.

Le Cesne A, Judson I, Crowther D, Rodenhuis S, Keizer HJ, Van Hoesel Q, Blay JY, Frisch J, Van Glabbeke M, Hermans C, Van Oosterom A, Tursz T, Verweij J. Le Cesne A, et al. J Clin Oncol. 2000 Jul;18(14):2676-84. doi: 10.1200/JCO.2000.18.14.2676. J Clin Oncol. 2000. PMID: 10894866 Clinical Trial.

2

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.

Le Cesne A, Antoine E, Spielmann M, Le Chevalier T, Brain E, Toussaint C, Janin N, Kayitalire L, Fontaine F, Genin J, et al. Le Cesne A, et al. Among authors: le chevalier t. J Clin Oncol. 1995 Jul;13(7):1600-8. doi: 10.1200/JCO.1995.13.7.1600. J Clin Oncol. 1995. PMID: 7541449 Clinical Trial.

3

Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectum.

Elias D, Farace F, Triebel F, Hattchouel JM, Pignon JP, Lecesne A, Rougier P, Lasser P, Duvillard P, Escudier B. Elias D, et al. J Am Coll Surg. 1995 Oct;181(4):303-10. J Am Coll Surg. 1995. PMID: 7551323 Clinical Trial.

4

[Chemotherapy of metastatic soft tissue sarcoma].

Le Cesne A. Le Cesne A. Presse Med. 1995 Sep 16;24(26):1214-20. Presse Med. 1995. PMID: 7567851 Review. French.

5

[Importance of the initial chemotherapy dose in the treatment of small cell lung carcinoma: therapeutic perspectives].

Le Chevalier T, Le Cesne A, Arriagada R. Le Chevalier T, et al. Among authors: le cesne a. Bull Cancer. 1995;82 Suppl 1:24s-28s. Bull Cancer. 1995. PMID: 7626850 Clinical Trial. French.

6

[Soft tissue sarcomas: general review].

Fizazi K, Cojean I, Le Cesne A, Kayitalire L, Le Chevalier T, Tursz T, Spielmann M. Fizazi K, et al. Among authors: le chevalier t, le cesne a. Bull Cancer. 1994 Oct;81(10):835-52. Bull Cancer. 1994. PMID: 7734766 Review. French.

7

The open reading frame I (ORF I)/ORF II part of the human T-cell leukemia virus type I X region is dispensable for p40tax, p27rex, or envelope expression.

Roithmann S, Pique C, Le Cesne A, Delamarre L, Pham D, Tursz T, Dokhélar MC. Roithmann S, et al. Among authors: le cesne a. J Virol. 1994 May;68(5):3448-51. doi: 10.1128/JVI.68.5.3448-3451.1994. J Virol. 1994. PMID: 8151807 Free PMC article.

8

Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.

Le Cesne A, Chabot G, Bérille J, Lucas C, Baud M, Gouyette A, Marty M, Le Chevalier T. Le Cesne A, et al. Among authors: le chevalier t. Lung Cancer. 1995 Aug;13(1):69-78. doi: 10.1016/0169-5002(95)00479-k. Lung Cancer. 1995. PMID: 8528641 Clinical Trial.

9

Dealing with initial chemotherapy doses: a new basis for treatment optimisation in limited small-cell lung cancer.

Le Cesne A, Le Chevalier T, Arriagada R. Le Cesne A, et al. Among authors: le chevalier t. Ann Oncol. 1995;6 Suppl 3:S53-6. doi: 10.1093/annonc/6.suppl_3.s53. Ann Oncol. 1995. PMID: 8616117 Free article. Review.

10

Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.

Blay JY, Chauvin F, Le Cesne A, Anglaret B, Bouhour D, Lasset C, Freyer G, Philip T, Biron P. Blay JY, et al. Among authors: le cesne a. J Clin Oncol. 1996 Feb;14(2):636-43. doi: 10.1200/JCO.1996.14.2.636. J Clin Oncol. 1996. PMID: 8636781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters